Oxford Pharmaceitical Sciences Limited Company Profile

05:29 EST 17th December 2018 | BioPortfolio

s a professional clinical research organisation, OPS is committed to a culture of quality and excellence and applies best practice throughout the business.

Working with major blue-chip clients, the company attracts and retains only the best people. Its commitment to career development enables OPS to employ a stable and experienced workforce delivering consistency, quality and an unparalleled level of service.

OPS forms a genuine partnership with clients, with staff becoming an integral part of the client's business. By combining its resources and expertise with those of the client, OPS achieves both critical development objectives and the successful completion of clinical trial programmes - on time, every time.

The organisation encourages pragmatic teamwork, proactive and responsive communication, coupled with a friendly, helpful and willing attitude. By employing a consultative approach to clinical research, OPS customises solutions to clients' specific needs, ensuring a fast, accurate and cost effective service.

Those services include:

Resource solutions

Biometric consultancy

Clinical research

Expanding rapidly, OPS is now a leading force in the clinical research arena, with in-house biometricians and field-based consultants engaging in ever more challenging research programmes for a growing portfolio of internationally-based pharmaceutical clients.


Unit 1A, Kingston Business Park
Kingston Bagpuize
OX13 5FE
United Kingdom


Phone: +44 (0) 1865 823823
Fax: +44 (0) 1865 821868

News Articles [939 Associated News Articles listed on BioPortfolio]

Isis Innovation: How the Oxford Sciences Innovation fund is promoting investment in the Oxfordshire region

Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...

Oxford Biomedica inks licensing agreement with Axovant Sciences

Gene and cell therapy group Oxford BioMedica has entered into an exclusive worldwide licensing agreement with Nasdaq-listed Axovant Sciences that will see the pair develop and commercialise OXB-102...

Axovant buys rights for Oxford BioMedica’s Parkinson’s candidate

Biopharmaceutical firm Axovant Sciences has agreed exclusive worldwide rights for the development and commercialisation of gene therapy company Oxford BioMedica’s...Read More... The post Axovant buy...

Axovant raises $25mm in PIPE to support licensing of OXB102 from Oxford BioMedica

Axovant Sciences Ltd. grossed $25mm through the private sale of 14.3mm common shares at $1.75 (a 17% premium) to parent Roivant Sciences. The company will use the proceeds to support development of OX...

Axovant, Oxford BioMedica sign $842.5m Parkinson’s disease deal

Axovant Sciences has signed an exclusive worldwide licensing agreement with Oxford BioMedica to develop and commercialise, OXB-10, to treat Parkinson’s disease.

Nitric Oxide conference gets under way in Oxford

Delegates from round the world have descended on Oxford for the 10th international conference of the Nitric Oxide Society, which has got under way. This year, the NIHR oxford Biomedical Research Centr...

Prof Duncan Richards appointed to key new Clinical Therapeutics role

A newly appointed professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) will lead Oxford’s answer to the key global challe...

Axovant Sciences: Expect A Crash After An Overhyped Deal With Oxford BioMedica

PubMed Articles [1222 Associated PubMed Articles listed on BioPortfolio]

Melancholic Habits: Burton's Anatomy and the Mind Sciences by Jennifer Radden Melancholic Habits: Burton's Anatomy and the Mind Sciences Jennifer Radden Oxford : Oxford University Press , 2017 , viii + 325 p., $45.00.

Cross-cultural adaptation and validation of the Romanian Oxford Shoulder Score.

The use of validated patient reported outcome scores is critical to the reporting and monitoring of the effectiveness of clinical treatment. The aim of this study was to translate and culturally valid...

Plasma Vitamin B12, Supplementation and Mortality.

BulkVis: a graphical viewer for Oxford nanopore bulk FAST5 files.

The Oxford Nanopore Technologies (ONT) MinION is used for sequencing a wide variety of sample types with diverse methods of sample extraction. Nanopore sequencers output FAST5 files containing signal ...

Systemic and Reflexive: Foundations of Cumulative Dis/Advantage and Life-Course Processes.

Clinical Trials [301 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [1256 Associated Companies listed on BioPortfolio]

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

Oxford Pharmaceitical Sciences Limited

s a professional clinical research organisation, OPS is committed to a culture of quality and excellence and applies best practice throughout the business.Working with major blue-chip clients, the com...

More Information about "Oxford Pharmaceitical Sciences Limited" on BioPortfolio

We have published hundreds of Oxford Pharmaceitical Sciences Limited news stories on BioPortfolio along with dozens of Oxford Pharmaceitical Sciences Limited Clinical Trials and PubMed Articles about Oxford Pharmaceitical Sciences Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Pharmaceitical Sciences Limited Companies in our database. You can also find out about relevant Oxford Pharmaceitical Sciences Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record